| Financier | Commitments |
|---|---|
| Reform and Reconstruction in Iraq MDTF | 2.00 |
| International Bank for Reconstruction and Development | 98.00 |
Iraq COVID-19 Vaccination Project
Abstract*
The project aims to support the Government of Iraq (GoI) in the procurement and deployment of COVID-19 vaccines. Support for systems strengthening to successfully deliver COVID-19 vaccines at scale will include, inter alia, procurement of consumables, cold chain equipment, equipment for health care waste management, the electronic registration system for vaccination, communication initiatives to address vaccine hesitancy, as well as any other necessary... Show More
Development Objective
The development objective is to support the Government of Iraq in the acquisition and deployment of COVID-19 vaccines.
Key Details
Project Details
P177038
Closed
Amr Elshalakani
Republic of Iraq
Iraq
September 7, 2021
(as of board presentation)
September 24, 2021
October 13, 2021
US$ 100.00 million
Ministry of Health and Environment
2022
US$ 100.00 million
N/A
October 31, 2023
June 30, 2023
TBD
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 98.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 98.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | 2.00 |
| Total Project Cost** | 100.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Sep 15, 2022 | IBRD-92970 | Loan Disb | 50,668.00 |
| Sep 5, 2023 | IBRD-92970 | Loan Disb | -36,852.92 |
| Apr 1, 2024 | IBRD-92970 | Int Charges | 3,135,786.50 |
| Apr 1, 2024 | IBRD-92970 | Int Charges | 9.93 |
| Apr 1, 2024 | IBRD-92970 | Int Charges | 6.56 |
| Apr 1, 2024 | IBRD-92970 | Int Charges | 51,040.93 |
| Sep 24, 2021 | IBRD-92970 | Loan Commitment | 98,000,000.00 |
| Oct 1, 2023 | IBRD-92970 | Int Charges | 56,269.37 |
| Oct 1, 2023 | IBRD-92970 | Int Charges | 204.55 |
| Oct 1, 2023 | IBRD-92970 | Int Charges | 2,837,068.20 |
| Oct 31, 2023 | IBRD-92970 | Loan Cancel | 40,804.64 |
| May 24, 2023 | IBRD-92970 | Loan Disb | 500,000.00 |
| Oct 19, 2023 | IBRD-92970 | Loan Disb | 12,587.75 |
| Apr 1, 2022 | IBRD-92970 | Int Charges | 127,698.32 |
| Dec 16, 2021 | IBRD-92970 | Loan Disb | 245,000.00 |
| Dec 16, 2021 | IBRD-92970 | Fee Charges | 245,000.00 |
| Nov 25, 2022 | IBRD-92970 | Int Charges | 824,748.80 |
| Oct 19, 2022 | IBRD-92970 | Loan Disb | 22,500,000.00 |
| Dec 30, 2021 | IBRD-92970 | Loan Disb | 11,994,840.00 |
| Dec 30, 2021 | IBRD-92970 | Loan Disb | 59,974,200.00 |
| Jan 14, 2022 | IBRD-92970 | Loan Disb | 200,000.00 |
| Aug 22, 2022 | IBRD-92970 | Loan Disb | 2,500,000.00 |
| Apr 19, 2023 | IBRD-92970 | Loan Disb | 18,752.53 |
| Apr 1, 2023 | IBRD-92970 | Int Charges | 104,219.80 |
| Apr 1, 2023 | IBRD-92970 | Int Charges | 29.33 |
| Apr 1, 2023 | IBRD-92970 | Int Charges | 2,194,104.50 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-04-03 |
| Procurement | Satisfactory | 2024-04-03 |
| Project Management | Moderately Satisfactory | 2024-04-03 |
| Financial Management | Satisfactory | 2024-04-03 |
| Progress towards achievement of PDO | Moderately Satisfactory | 2024-04-03 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-04-03 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of specific priority populations fully vaccinated Value 5.00 43.94 70.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment Percentage of fully vaccinated priority groups who are female Value 35.00 43.00 50.00 Date July 23, 2021 June 30, 2023 June 30, 2023 Comment Number of project-supported COVID-19 vaccinations sites with adequate health care waste management for vaccination Value 0.00 181.00 156.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment Number of COVID-19 vaccine doses acquired through project financing Value 0.00 5966470.00 6000000.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of administered doses which are captured in the national vaccination digital registry Value 0.00 81.95 95.00 Date September 3, 2021 June 30, 2023 June 30, 2023 Comment Percentage of feedback cases registered in the project's grievance redress mechanism (GRM) in the last quarter addressed within a timeframe specified and publicly communicated by the project Value 0.00 0.00 95.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment Percentage of vaccination sites which publicized detailed performance data on a regular basis in the last quarter Value 0.00 0.00 90.00 Date September 3, 2021 June 30, 2023 June 30, 2023 Comment Percentage of vaccination sites visited by the project TPMA in the last quarter Value 0.00 97.00 50.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment Percentage of vaccination sites with functional cold chain Value 0.00 100.00 100.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment Number of public discussion meetings conducted on the results of the TPMA Value 0.00 11.00 4.00 Date September 3, 2021 June 30, 2023 June 30, 2023 Comment Percentage of reported serious AEFI cases for which investigations were initiated within 48 hours Value 0.00 50.00 80.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment Number of health workers who received training in vaccination with GBV-related content Value 0.00 14000.00 1000.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment Number of communication initiatives supported by the project to address vaccine hesitancy Value 0.00 1.00 5.00 Date September 4, 2021 June 30, 2023 June 30, 2023 Comment